PITCHAIAH MANDAVA's research topics

PITCHAIAH MANDAVA

Concepts (162)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with PITCHAIAH MANDAVA's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that PITCHAIAH MANDAVA has written about over time.

Immunoglobulin Fab Fragments, 5 publications between 2004 and 2008, average publication date September 2005. Intracranial Thrombosis, 2 publications between 2002 and 2009, average publication date December 2005. Anticoagulants, 4 publications between 2004 and 2017, average publication date December 2007. Research Design, 2 publications between 2009 and 2010, average publication date August 2009. Clinical Trials as Topic, 5 publications between 2007 and 2015, average publication date October 2010. Data Interpretation, Statistical, 3 publications between 2009 and 2015, average publication date April 2011. Models, Statistical, 4 publications between 2007 and 2019, average publication date May 2012. Brain Ischemia, 15 publications between 2004 and 2022, average publication date May 2013. Stroke, 27 publications between 2004 and 2022, average publication date June 2013. Thrombolytic Therapy, 12 publications between 2004 and 2022, average publication date April 2014. Treatment Outcome, 20 publications between 2004 and 2024, average publication date August 2014. Fibrinolytic Agents, 15 publications between 2005 and 2022, average publication date February 2015. Drug Evaluation, Preclinical, 1 publications between 2016 and 2016, average publication date March 2016. Tissue Plasminogen Activator, 13 publications between 2008 and 2022, average publication date May 2016. Neuroprotective Agents, 3 publications between 2013 and 2019, average publication date June 2016. Randomized Controlled Trials as Topic, 6 publications between 2009 and 2022, average publication date October 2016. Catheterization, 1 publications between 2019 and 2019, average publication date March 2019. Hematoma, 1 publications between 2019 and 2019, average publication date March 2019. Cerebral Hemorrhage, 5 publications between 2012 and 2024, average publication date July 2019.

Immunoglobulin Fab Fragments
Intracranial Thrombosis
Anticoagulants
Research Design
Clinical Trials as Topic
Data Interpretation, Statistical
Models, Statistical
Brain Ischemia
Stroke
Thrombolytic Therapy
Treatment Outcome
Fibrinolytic Agents
Drug Evaluation, Preclinical
Tissue Plasminogen Activator
Neuroprotective Agents
Randomized Controlled Trials as Topic
Catheterization
Hematoma
Cerebral Hemorrhage

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Immunoglobulin Fab Fragments	5	2004	2008	September 2005
Intracranial Thrombosis	2	2002	2009	December 2005
Anticoagulants	4	2004	2017	December 2007
Research Design	2	2009	2010	August 2009
Clinical Trials as Topic	5	2007	2015	October 2010
Data Interpretation, Statistical	3	2009	2015	April 2011
Models, Statistical	4	2007	2019	May 2012
Brain Ischemia	15	2004	2022	May 2013
Stroke	27	2004	2022	June 2013
Thrombolytic Therapy	12	2004	2022	April 2014
Treatment Outcome	20	2004	2024	August 2014
Fibrinolytic Agents	15	2005	2022	February 2015
Drug Evaluation, Preclinical	1	2016	2016	March 2016
Tissue Plasminogen Activator	13	2008	2022	May 2016
Neuroprotective Agents	3	2013	2019	June 2016
Randomized Controlled Trials as Topic	6	2009	2022	October 2016
Catheterization	1	2019	2019	March 2019
Hematoma	1	2019	2019	March 2019
Cerebral Hemorrhage	5	2012	2024	July 2019

MANDAVA's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (162)

Explore

Co-Authors (14)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors